Announcement on Further Improving Matters Related to Drug Association Review, Approval and Supervision
In order to implement the opinions of the general office of the CPC Central Committee and the general office of the State Council on Deepening the Reform of the Review and Approval System and Encouraging the Innovation of Drugs and Medical Devices (Ting Zi [2017] No. 42), the former NMPA issued the announcement on Adjusting the Review and Approval Items of APIs, Pharmaceutical Excipients and Drug Packaging Materials (2017 No. 146). On July 16st, NMPA further clarified the announcement on relevant matters concerning the association review, approval and supervision of APIs, pharmaceutical excipients, direct-contact packaging materials and containers of drugs (hereinafter referred to as the original auxiliary package) and pharmaceutical preparations.
2019-07-23